References
Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D'Haens G, Wolf DC, Kron M, Tighe MB, Lazar A, Thakkar RB (2012) Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 142(2):257–265. doi:10.1053/j.gastro.2011.10.032, e251-253
Lapp RT, Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M (2011) Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease. Mol Imaging Biol: MIB: Off Publ Acad Mol Imaging 13(3):573–576. doi:10.1007/s11307-010-0367-0
Meisner RS, Spier BJ, Einarsson S, Roberson EN, Perlman SB, Bianco JA, Taylor AJ, Einstein M, Jaskowiak CJ, Massoth KM, Reichelderfer M (2007) Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis 13(8):993–1000. doi:10.1002/ibd.20134
Lemberg DA, Issenman RM, Cawdron R, Green T, Mernagh J, Skehan SJ, Nahmias C, Jacobson K (2005) Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 11(8):733–738
Disclosure statement
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parbo, P., Stribolt, K., Rittig, C.S. et al. Active ulcerative colitis diagnosed by 18F-FDG PET/CT in an anti-TNF alpha treated patient with no visible luminal lesions on colonoscopy. Int J Colorectal Dis 29, 643–644 (2014). https://doi.org/10.1007/s00384-014-1840-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-014-1840-z